News
Canadian wildfire smoke has entered the Upper Midwest and poses significant health impacts in the hardest-hit areas.
3d
MedPage Today on MSNPulmonary Rehabilitation for COPD Pushes ForwardHome-based pulmonary rehabilitation has been slowly gaining momentum for chronic obstructive pulmonary disease (COPD), but ...
3d
MedPage Today on MSNEasing Airway Assaults in COPDFor COPD patients, the adage holds true: "the first way to get out of a hole is to quit digging one," said Christopher Mosher ...
Last fall, the hospital’s pharmacy team launched an effort aimed at cutting readmission rates for COPD, which are notoriously ...
Topline results were announced from two phase 3 trials evaluating itepekimab in former smokers with inadequately controlled COPD.
6d
Pharmaceutical Technology on MSNSanofi and Regeneron report results from two Phase III trials of COPD treatmentSanofi and Regeneron have reported that the Phase III AERIFY-1 trial of the fully human monoclonal antibody itepekimab.
In light of the significant drop in Regeneron’s stock price, a natural question emerges: is REGN now a viable buying ...
(Reuters) -Regeneron shares fell nearly 18% on Friday after its experimental drug for patients with a type of lung condition ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results